Developing Digital Technologies for Neurodegenerative Diseases
Parkinson’s
Alzheimer’s
Huntington’s
Who We Are
At ClearSky we are passionate about improving the lives of people affected by neurodegenerative conditions. We combine the expertise of a diverse team of professionals from AI & Machine Learning, consultant clinical neurology, and seasoned pharmaceutical and MedTech industry professionals.
Our founder, Professor Stephen Smith, is a visionary leader who has dedicated years of academic work to the application of machine learning in medical research.
ClearSky has a track record of developing devices for Parkinson’s, Huntingdon’s, and our latest research is tackling the diagnosis of dementia – find out more
What We Do
Services
ClearSky offers AI/ML services for clinical research and product development in neurodegenerative conditions. With expertise in developing CE-marked medical devices and supporting global clinical studies, we are the go-to-expert in using AI and Machine Learning to address complex medical challenges.
Get in touch
The Catalyst
Baird Lane
York
YO10 5GA
United Kingdom
+44 (0)1904 322351